CSChaitanya Sudrik

Chaitanya Sudrik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chaitanya Sudrik has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Jicong Cao

    Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA

    7 shared publications
  • Manish Arha

    Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA

    7 shared publications
  • Ravi S. Kane

    School of Chemical & Biomolecular Engineering Georgia Institute of Technology Atlanta Georgia USA

    4 shared publications
  • David V. Schaffer

    Department of Chemical Engineering, University of California Berkeley, Berkeley, CA 94792

    3 shared publications
  • David Vernon Schaffer

    University of California, Berkeley

    3 shared publications
  • Ravi S. Kane

    Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, USA

    3 shared publications

Latest Publications

  • Open Access

    Review of emerging concepts in nanotoxicology: opportunities and challenges for safer nanomaterial design

    by Ajay Vikram Singh, Peter Laux, Andreas Luch, Chaitanya Sudrik, Stefan Wiehr, Anna-Maria Wild, Giulia Santomauro, Joachim Bill, Metin Sitti

    Nanotoxicology and nanosafety has been a topic of intensive research for about more than 20 years. Nearly 10,000 research papers have been published on the topic, yet there exists a gap in terms of understanding and ways to harmonize nanorisk assessment. In this review, we revisit critically ignored parameters of nanoscale materials (e.g. band gap factor, phase instability and silver leaching problem, defect and instability plasmonic vs. inorganic particles) versus their biological counterparts (cell batch-to-batch heterogeneity, biological barrier model design, cellular functional characteristics) which yield variability and nonuniformity in results. We also emphasize system biology approaches to integrate the high throughput screening methods coupled with in-vivo and in-silico modelling to ensure quality in nanosafety research. We emphasize and highlight the recommendation regarding bridging the mechanistic gaps in fundamental research and predictive biological response in nanotoxicology. The research community has to develop visions to predict the unforeseen problems that do not exist yet in context with nanotoxicity and public health hazards due to the burgeoning use of nanomaterial in consumer’s product.


  • Kirkwood–Buff-Derived Alcohol Parameters for Aqueous Carbohydrates and Their Application to Preferential Interaction Coefficient Calculations of Proteins

    by Theresa Cloutier, Chaitanya Sudrik, Hasige A. Sathish, Bernhardt L. Trout

    The CHARMM36 carbohydrate parameter set did not adequately reproduce experimental thermodynamic data of carbohydrate interactions with water or proteins or carbohydrate self-association; thus, a new nonbonded parameter set for carbohydrates was developed. The parameters were developed to reproduce experimental Kirkwood–Buff integral values, defined by the Kirkwood–Buff theory of solutions, and applied to simulations of glycerol, sorbitol, glucose, sucrose, and trehalose. Compared to the CHARMM36 carbohydrate parameters, these new Kirkwood–Buff-based parameters reproduced accurately carbohydrate self-association and the trend of activity coefficient derivative changes with concentration. When using these parameters, preferential interaction coefficients calculated from simulations of these carbohydrates and the proteins lysozyme, bovine serum albumin, α-chymotrypsinogen A, and RNase A agreed well with the experimental data, whereas use of the CHARMM36 parameters indicated preferential inclusion of carbohydrates, in disagreement with the experiment. Thus, calculating preferential interaction coefficients from simulations requires using a force field that accurately reproduces trends in the thermodynamic properties of binary excipient–water solutions, and in particular the trend in the activity coefficient derivative. Finally, the carbohydrate–protein simulations using the new parameters indicated that the carbohydrate size was a major factor in the distribution of different carbohydrates around a protein surface.


  • Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies

    by Chaitanya Sudrik, Theresa Cloutier, Phuong Pham, Hardeep S. Samra, Bernhardt L. Trout

    Preferential interactions of weakly interacting formulation excipients govern their effect on the equilibrium and kinetics of several reactions of protein molecules in solution. Using vapor pressure osmometry, we characterized the preferential interactions of commonly used excipients trehalose, L-arginine.HCl and NaCl with three therapeutically-relevant, IgG1 monoclonal antibodies that have similar size and shape, but differ in their surface hydrophobicity and net charge. We further characterized the effect of these excipients on the reversible self-association, aggregation and viscosity behavior of these antibody molecules. We report that trehalose, L-arginine.HCl and NaCl are all excluded from the surface of the three IgG1 monoclonal antibodies, and that the exclusion behavior is linearly related to the excipient molality in the case of trehalose and NaCl, whereas a non-linear behavior is observed for L-arginine.HCl. Interestingly, we find that the magnitude of trehalose exclusion depends upon the nature of the protein surface. Such behavior is not observed in case of NaCl and L-arginine.HCl as they are excluded to the same extent from the surface of all three antibody molecules tested in this study. Analysis of data presented in this study provides further insight into the mechanisms governing excipient-mediated stabilization of mAb formulations.


  • Open Access

    A universal strategy for regulating mRNA translation in prokaryotic and eukaryotic cells

    by Jicong Cao, Manish Arha, Chaitanya Sudrik, Abhirup Mukherjee, Xia Wu, Ravi S. Kane

    We describe a simple strategy to control mRNA translation in both prokaryotic and eukaryotic cells which relies on a unique protein–RNA interaction. Specifically, we used the Pumilio/FBF (PUF) protein to repress translation by binding in between the ribosome binding site (RBS) and the start codon (in Escherichia coli), or by binding to the 5′ untranslated region of target mRNAs (in mammalian cells). The design principle is straightforward, the extent of translational repression can be tuned and the regulator is genetically encoded, enabling the construction of artificial signal cascades. We demonstrate that this approach can also be used to regulate polycistronic mRNAs; such regulation has rarely been achieved in previous reports. Since the regulator used in this study is a modular RNA-binding protein, which can be engineered to target different 8-nucleotide RNA sequences, our strategy could be used in the future to target endogenous mRNAs for regulating metabolic flows and signaling pathways in both prokaryotic and eukaryotic cells.


  • Characterization of an optogenetic translation activation system

    by Jicong Cao, Manish Arha, Chaitanya Sudrik, Ravi S. Kane, Lukasz J. Bugaj, David V. Schaffer

    Considerable work has focused on developing systems to control cellular events using light, which is nontoxic to most mammalian cells and can be delivered with spatiotemporal control. We have developed a genetically encoded optogenetic system in which blue light activates target mRNA translation in mammalian cells. Specifically, we used blue light to induce the reconstitution of an RNA binding domain and a translation initiation domain, thereby activating target mRNA translation downstream of binding sites. We found that the influence of the ratio of the amount of reporter plasmid to that of effector plasmid on translation activation is small, which demonstrates the robustness of system to plasmid amounts. We also found that increasing the number of binding sites (aptamers) on the target mRNA enhanced translation activation in a light-sensitive manner.


  • Design of a translational repression based RNA switch in mammalian cells

    by Chaitanya Sudrik, Manish Arha, Jicong Cao, Ravi S. Kane, David V. Schaffer

    Given the importance of molecular switches for the construction of artificial gene circuits, we developed a novel genetically encoded translational repression based switch that incorporates two copies of bovine immunodeficiency virus (BIV) TAR-based RNA hairpins in the 5'-untranslated region (UTR). We observed a 7-fold decrease in translational efficiency for the translational repression switch in the presence of BIV Tat ligand. We further characterized the effect of increasing amounts of BIV Tat peptide on the translational efficiency of the repression switch.

  • Bidirectional Regulation of mRNA Translation in Mammalian Cells by Using PUF Domains

    by Jicong Cao, Manish Arha, Chaitanya Sudrik, David V. Schaffer, Ravi S. Kane

    The regulation of gene expression is crucial in diverse areas of biological science, engineering, and medicine. A genetically encoded system based on the RNA binding domain of the Pumilio and FBF (PUF) proteins was developed for the bidirectional regulation (i.e., either upregulation or downregulation) of the translation of a target mRNA. PUF domains serve as designable scaffolds for the recognition of specific RNA elements and the specificity can be easily altered to target any 8‐nucleotide RNA sequence. The expression of a reporter could be varied by over 17‐fold when using PUF‐based activators and repressors. The specificity of the method was established by using wild‐type and mutant PUF domains. Furthermore, this method could be used to activate the translation of target mRNA downstream of PUF binding sites in a light‐dependent manner. Such specific bidirectional control of mRNA translation could be particularly useful in the fields of synthetic biology, developmental biology, and metabolic engineering.


  • Bidirectional Regulation of mRNA Translation in Mammalian Cells by Using PUF Domains

    by Jicong Cao, Manish Arha, Chaitanya Sudrik, David V. Schaffer, Ravi S. Kane

    The regulation of gene expression is crucial in diverse areas of biological science, engineering, and medicine. A genetically encoded system based on the RNA binding domain of the Pumilio and FBF (PUF) proteins was developed for the bidirectional regulation (i.e., either upregulation or downregulation) of the translation of a target mRNA. PUF domains serve as designable scaffolds for the recognition of specific RNA elements and the specificity can be easily altered to target any 8‐nucleotide RNA sequence. The expression of a reporter could be varied by over 17‐fold when using PUF‐based activators and repressors. The specificity of the method was established by using wild‐type and mutant PUF domains. Furthermore, this method could be used to activate the translation of target mRNA downstream of PUF binding sites in a light‐dependent manner. Such specific bidirectional control of mRNA translation could be particularly useful in the fields of synthetic biology, developmental biology, and metabolic engineering.


  • Translational repression using BIV Tat peptide–TAR RNA interaction in mammalian cells

    by Chaitanya Sudrik, Manish Arha, Jicong Cao, David V. Schaffer, Ravi S. Kane

    We developed a strategy to create novel genetically encoded switches based on translational repression. We illustrated its efficacy by incorporating two copies of an RNA hairpin in the 5′-untranslated region (UTR) of a target mRNA and demonstrating 7-fold translational repression upon expression of a ligand – the BIV Tat peptide.


  • Light-inducible activation of target mRNA translation in mammalian cells

    by Jicong Cao, Manish Arha, Chaitanya Sudrik, Lukasz J. Bugaj, David V. Schaffer, Ravi S. Kane

    A genetically encoded optogenetic system was constructed that activates mRNA translation in mammalian cells in response to light. Blue light induces the reconstitution of an RNA binding domain and a translation initiation domain, thereby activating target mRNA translation downstream of the binding sites.